Deficiency of Atg6 impairs beneficial effect of metformin on intestinal stem cell aging in Drosophila
Deficiency of Atg6 impairs beneficial effect of metformin on intestinal stem cell aging in Drosophila
复制标题
DOI:
10.1016/j.bbrc.2018.02.191
复制
发表时间:
2018-03-25
影响因子:
3.1
通讯作者:
Yoo, Mi-Ae
中科院分区:
文献类型:
--
作者:
Na, Hyun-Jin;Pyo, Jung-Hoon;Yoo, Mi-Ae
Age-related changes of adult stem cell are crucial for tissue aging and age-related diseases. Thus, clarifying mechanisms to prevent adult stem cell aging is indispensable for healthy aging. Metformin, a drug for type 2 diabetes, has been highlighted for its anti-aging and anti-cancer effect. In Drosophila intestinal stem cell (ISC), we previously reported the inhibitory effect of metformin on age-related phenotypes of ISC. Here, we showed that knockdown of Atg6, a crucial autophagy-related factor, in ISC induces age related phenotypes of ISC such as hyperproliferation, centrosome amplification, and DNA damage accumulation. Then, we revealed that metformin inhibits ISC aging phenotypes in Atg6-dependent manner. Taken together, our study suggests that Atg6 is required for the inhibitory effect of metformin on ISC aging, providing an intervention mechanism of metformin on adult stem cell aging. (C) 2018 Elsevier Inc. All rights reserved.